TransMedics Group, Inc. — Director's Dealing 2024

Jun 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-06-03

Reporting Person: Gordon Stephen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-03	Common Stock	M	2060	$38.46	Acquired	23359	Direct
2024-06-03	Common Stock	S	2060	$135.93	Disposed	21299	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-03	Stock Option (Right to Buy)	$38.46	M	2060	Disposed	2031-02-24	Common Stock (2060)	Direct

Footnotes

F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.

F2: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.